The short answer
A multivitamin can change warfarin response if its ingredients change vitamin K intake. The effect depends on the formula and baseline vitamin K status; warfarin does not create a general requirement to take a multivitamin. Starting, stopping or switching a vitamin K-containing formula should be discussed with the anticoagulation service.
What this answer covers
Oral multivitamins with oral warfarin, specifically vitamin K1-containing formulations in the direct study. Prenatal products and multivitamins without vitamin K are not assumed to have the same interaction.
- Supplement or preparation
- Multivitamins
- Medication ingredient
- warfarin
What does the evidence show?
A small prospective study tested a multivitamin containing 25 micrograms of vitamin K1 daily for four weeks. All nine participants selected for low vitamin K1 status developed a subtherapeutic INR, compared with one of seven whose status was normal. The low-status group needed a modest increase in warfarin dose under a study algorithm. This shows that even a relatively small intake change may matter in selected patients. It does not mean every multivitamin will lower INR or that everyone taking warfarin needs supplementation.
Which forms and conditions matter?
Read the full ingredient list and amount per daily serving. A product may change formulation while retaining a similar name, and prenatal formulas are not chemically equivalent to a standard adult multivitamin. The research links the observed effect to a vitamin K1-containing preparation; it cannot be assigned to an unspecified multivitamin independently of its ingredients.
What should I discuss with my care team?
Keep a consistent supplement routine once the treating team has incorporated it into warfarin management. Ask before changing brands, stopping a product or adding an extra vitamin K supplement. The clinician may arrange INR checks around a change. Do not double or skip warfarin to compensate. There is no evidence here that taking the multivitamin at a different hour avoids the vitamin K effect.
How certain is the answer?
The study was small and deliberately selected people with low or normal vitamin K1 status. It cannot predict a given person's response or define a universally safe dose. The original statement should be read as a need to review and monitor a formula, not an instruction that adequate multivitamin intake is required by warfarin therapy.
Evidence and practical considerations
Timing & monitoring
A multivitamin can change warfarin response if its ingredients change vitamin K intake. The effect depends on the formula and baseline vitamin K status; warfarin does not create a general requirement to take a multivitamin. Starting, stopping or switching a vitamin K-containing formula should be discussed with the anticoagulation service.
- Exact scope
- Oral multivitamins with oral warfarin, specifically vitamin K1-containing formulations in the direct study. Prenatal products and multivitamins without vitamin K are not assumed to have the same interaction. with Oral warfarin, including warfarin sodium tablets with the warfarin active moiety.
- Medication form and route
- oral warfarin
- Timing or duration
- Study-specific durations are described in each source exposure; no universally safe exposure duration has been established.
What remains uncertain
- The study was small and deliberately selected people with low or normal vitamin K1 status. It cannot predict a given person's response or define a universally safe dose. The original statement should be read as a need to review and monitor a formula, not an instruction that adequate multivitamin intake is required by warfarin therapy.
Factors that may matter: Exact supplement preparation and other ingredients; Starting, stopping or changing supplement intake; Baseline anticoagulation control and clinician-supervised monitoring.
Read the supporting source summaries
Source 1: current U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral warfarin sodium tablets.
The label advises closer INR monitoring when botanicals are started or stopped, identifies variable botanical composition and lists selected potential interactions. Vitamin K intake should remain consistent.
How this applies: Oral warfarin sodium has warfarin as its active moiety. Label-level botanical and vitamin K monitoring advice applies; it is not proof of this exact supplement effect. Oral multivitamins with oral warfarin, specifically vitamin K1-containing formulations in the direct study. Prenatal products and multivitamins without vitamin K are not assumed to have the same interaction.
Regulatory precautions do not quantify the incidence for every exact preparation or prove an interaction for an unlisted ingredient. Warfarin sodium is bridged to the warfarin active moiety only for the oral product.
Source 2: peer-reviewed original research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 16 warfarin-treated adults selected for low vitamin K1 status (nine) or normal status (seven).
Subtherapeutic INR occurred in nine of nine low-status patients and one of seven normal-status patients; median INR fell 0.51 in the low-status group.
How this applies: Direct low-dose vitamin K1-containing multivitamin study. Applies to vitamin K1 and to multivitamins containing it; not evidence that all multivitamins require or produce the same effect. Exact package scope: Oral multivitamins with oral warfarin, specifically vitamin K1-containing formulations in the direct study. Prenatal products and multivitamins without vitamin K are not assumed to have the same interaction.
Small selected cohort; formulation contained multiple ingredients and results do not apply to every multivitamin. This is evidence of a formulation-dependent interaction, not a general requirement for supplementation.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original evidence and contradictory findings assessed for this exact pair. Article drafted and existing statements adjudicated. Clinical sign-off has not been recorded. | |
| Research summary published |
Article revision: f17988ef9d2d17be
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.